| Date of Evaluation | Fertility (€) | Rel (%) | CI (days) | Survival (%) | Type of Proof |
|---|---|---|---|---|---|
| Sep 2025 | -122 | 87 | 5.79 | -3.69 | BLENDED GS |
| May 2025 | -67 | 87 | 3.03 | -2.36 | BLENDED GS |
| Date of Evaluation | Fertility (€) | Rel (%) | CI (days) | Survival (%) | Type of Proof |
|---|---|---|---|---|---|
| Sep 2025 | -122 | 87 | 5.79 | -3.69 | BLENDED GS |
| May 2025 | -67 | 87 | 3.03 | -2.36 | BLENDED GS |
| Number of IRL Daughters | Number of IRL Herds | Type of Proof |
|---|---|---|
| 332 | 131 | BLENDED GS |
| Date of Evaluation | Hrd | Dau | Herd Mates | Average CI | Average Survival | ||
|---|---|---|---|---|---|---|---|
| Dau | Herd Mates | Dau | Herd Mates | ||||
| Sep 2025 | 131 | 332 | 3276 | 396 | 393 | 86 | 89 |
| May 2025 | 131 | 332 | 3276 | 396 | 393 | 86 | 89 |
| Date of Evaluation | Hrd | Dau | Herd Mates | Average CI | Average Survival | ||
|---|---|---|---|---|---|---|---|
| Dau | Herd Mates | Dau | Herd Mates | ||||
| Sep 2025 | 131 | 332 | 3276 | 396 | 393 | 86 | 89 |
| May 2025 | 131 | 332 | 3276 | 396 | 393 | 86 | 89 |
| Parity 1-2 | Parity 2-3 | Parity 3-4 | Parity 4-5 | Parity 5-6 | |
|---|---|---|---|---|---|
| No. Daughters | 296 | 234 | 180 | 107 | 81 |
| No. Herds | 104 | 93 | 75 | 52 | 40 |
| No. without completed record | 28 | 41 | 42 | 27 | 21 |
| Parity 1-2 | Parity 2-3 | Parity 3-4 | Parity 4-5 | Parity 5-6 | |
|---|---|---|---|---|---|
| No. Daughters | 296 | 234 | 180 | 107 | 81 |
| No. Herds | 104 | 93 | 75 | 52 | 40 |
| No. without completed record | 28 | 41 | 42 | 27 | 21 |
| Number of IRL Daughters | Number of IRL Herds | Type of Proof |
|---|---|---|
| 332 | 131 | BLENDED GS |
| Country | Fertility | Survival | ||
|---|---|---|---|---|
| Daughters | Herds | Daughters | Herds | |
| AUS | 0 | 0 | 0 | 0 |
| CAN | 0 | 0 | 0 | 0 |
| DFS | 0 | 0 | 0 | 0 |
| FRA | 0 | 0 | 0 | 0 |
| GBR | 1098 | 278 | 1535 | 351 |
| GER | 0 | 0 | 0 | 0 |
| ITA | 0 | 0 | 0 | 0 |
| NLD | 272 | 240 | 299 | 257 |
| NZL | 0 | 0 | 0 | 0 |
| USA | 0 | 0 | 0 | 0 |